These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28911291)

  • 1. Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an update.
    Frei D; Stowell KM; Langton EE; McRedmond L; Pollock NA; Bulger TF
    Anaesth Intensive Care; 2017 Sep; 45(5):611-618. PubMed ID: 28911291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.
    Pollock N; Langton EE; Stowell KM; Bulger TF
    Anaesth Intensive Care; 2011 Sep; 39(5):887-94. PubMed ID: 21970134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected malignant hyperthermia reactions in New Zealand.
    Pollock AN; Langton EE; Couchman K; Stowell KM; Waddington M
    Anaesth Intensive Care; 2002 Aug; 30(4):453-61. PubMed ID: 12180584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil].
    Almeida da Silva HC; Ferreira G; Rodrigues G; Santos JMD; Andrade PV; Hortense A; Vaz Perez M; Amaral JLGD
    Braz J Anesthesiol; 2019; 69(2):152-159. PubMed ID: 30935497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosis.
    Chan TY; Bulger TF; Stowell KM; Gillies RL; Langton EE; Street NE; Pollock NA
    Anaesth Intensive Care; 2017 Nov; 45(6):707-713. PubMed ID: 29137581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test.
    Bendixen D; Skovgaard LT; Ording H
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):480-4. PubMed ID: 9150775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
    von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update.
    Barnes C; Stowell KM; Bulger T; Langton E; Pollock N
    Anaesth Intensive Care; 2015 Jan; 43(1):98-104. PubMed ID: 25579296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anaesthesias in malignant hyperthermia negative patients.
    Islander G; Ranklev-Twetman E
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):819-21. PubMed ID: 7484041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of malignant hyperthermia: less fulminant, more insidious.
    Heytens L; Forget P; Scholtès JL; Veyckemans F
    Anaesth Intensive Care; 2015 Jul; 43(4):506-11. PubMed ID: 26099765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia.
    Bollig G; Mohr S; Raeder J
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative malignant hyperthermia episodes in patients who received "safe" anaesthetics.
    Grinberg R; Edelist G; Gordon A
    Can Anaesth Soc J; 1983 May; 30(3 Pt 1):273-6. PubMed ID: 6336548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaesthesia for patients with arthrogryposis multiplex congenita: what is the risk of malignant hyperthermia?
    Baines DB; Douglas ID; Overton JH
    Anaesth Intensive Care; 1986 Nov; 14(4):370-2. PubMed ID: 3565726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia: how to spot it early.
    Haslego SS
    RN; 2002 Jul; 65(7):31-5; quiz 36. PubMed ID: 12136527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
    Bonciu M; de la Chapelle A; Delpech H; Depret T; Krivosic-Horber R; Aimé MR
    Paediatr Anaesth; 2007 Feb; 17(2):180-2. PubMed ID: 17238892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.